A composite score (0–100) computed from nine weighted health dimensions: Financial Vitality (25%), Delivery & Execution (18%), Culture & People (12%), C-Suite (10%), Market & Competition (8%), GTM (8%), Vision & Strategy (7%), Product & Customer (7%), and Risk (5%). The score is benchmarked against peer cohorts by industry, stage, and size. A score above 75 indicates healthy operations; below 60 signals structural risk.
The Zoe Score cuts through boardroom narratives to forecast post-close performance. A single number benchmarked against peer cohorts tells you which operational dimensions pose the highest risk to value creation. PE firms use it to validate thesis assumptions, identify value levers for the first 100 days, and surface integration risks before close. A score above 75 suggests the operational machine will handle leverage; below 60 flags structural problems that no financial model can engineer away. It predicts revenue stability, retention outcomes, and leadership burnout risk.
Zoe computes the score by weighting nine health dimensions: Financial Vitality (25%), Delivery & Execution (18%), Culture & People (12%), C-Suite (10%), Market & Competition (8%), Go-to-Market (8%), Vision & Strategy (7%), Product & Customer (7%), and Risk (5%). Each dimension pulls directly from behavioral metadata and automated data feeds from accounting, CRM, GitHub, Slack, and public channels. Scores refresh weekly and benchmark against stage-, industry-, and size-matched peer cohorts to control for survivorship.
Communication Pattern Analysis in Due Diligence
Operational Due Diligence
Measuring Decision Velocity Before You Buy
Operational Due Diligence
Execution Health: Is the Company Actually Shipping?
Operational Due Diligence
Operational vs Financial Due Diligence
Operational Due Diligence
Evaluating Leadership Effectiveness from Data
Culture Due Diligence
Identifying Culture Clash Before It Kills the Deal
Culture Due Diligence
Company Health Scoring: Beyond Financial KPIs
Portfolio Monitoring
Early Warning Signals in Portfolio Companies
Portfolio Monitoring
Benchmarking Portfolio Companies Against Peers
Portfolio Monitoring
Data-Driven Board Reporting for PE Firms
Portfolio Monitoring
The 100-Day Post-Acquisition Integration Plan
Post-Acquisition Integration
Integration Health Metrics That Actually Predict Success
Post-Acquisition Integration
Scaling Dysfunction: Why Fast-Growing Companies Slow Down
Organizational Health
Measuring Cross-Team Collaboration from Data
Organizational Health
Evaluating the Management Team from Behavioral Data
Human Capital Due Diligence
Behavioral Data Analysis for Investment Decisions
AI-Powered Due Diligence
Predictive Company Health Scoring with AI
AI-Powered Due Diligence
The 24-Hour Diagnostic: How Speed Doesn't Mean Shortcuts
AI-Powered Due Diligence
You have a deal on the table. Run a Zoe diagnostic before you sign.
Join 200+ firms on the waitlist
